UGC CARE norms ugc approved journal norms IJRTI Research Journal

WhatsApp
Click Here

International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 8

Issue Published : 80

Article Submitted : 5819

Article Published : 3222

Total Authors : 8187

Total Reviewer : 541

Total Countries : 71

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: PHARMACOGENETICS OF ANTIPLATELET THERAPY
Authors Name: Shivam Prabhakar Pawar , Pallavi Tukaram Jadhav
Download E-Certificate: Download
Author Reg. ID:
IJRTI_184408
Published Paper Id: IJRTI2210068
Published In: Volume 7 Issue 10, October-2022
DOI:
Abstract: Antiplatelet therapy is used in the treatment of patient with acute coronary syndrome stroke and individuals undergoing percutaneous coronary intervention. Platelets are small cells in blood that body is used to form clots and prevent bleeding. Clotting can take place on the exclusive of arteries and mains to heart attack or stroke. Antiplatelet therapy decreases the chances of heart attack. Antiplatelet treatment is a drug treatment that decrease the platelet aggregation. They are used in patients with angina who are going to have an angioplasty or stent procedure. The used in antiplatelet therapy are Aspirin, Clopidogrel, Glycoprotein inhibitors, Prasugrel, Ticagrelor. Antiplatelet therapy is used in various diseases are COVID-19, Ischemic stroke, cardiovascular diseases.
Keywords: Pharmacogenetics, Antiplatelet therapy, Disorders, Blood clotting, Receptors, Platelet.
Cite Article: "PHARMACOGENETICS OF ANTIPLATELET THERAPY ", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 10, page no.509 - 516, October-2022, Available :http://www.ijrti.org/papers/IJRTI2210068.pdf
Downloads: 000202329
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2210068
Registration ID:184408
Published In: Volume 7 Issue 10, October-2022
DOI (Digital Object Identifier):
Page No: 509 - 516
Country: Ahmednagar, Maharastra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2210068
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2210068
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Join RMS/Earn 300

IJRTI

Indexing Partner